![]() |
市場調査レポート
商品コード
1576636
圧迫療法の市場規模、シェア、予測、動向分析:製品別(包帯、ストッキング、テープ、ポンプ)手技別(静的、動的)状態別(下肢静脈瘤、リンパ浮腫、下腿潰瘍)流通別(eコマース、病院) - 2030年までの世界予測Compression Therapy Market Size, Share, Forecast, & Trends Analysis by Product (Bandages, Stockings, Tapes, Pumps) Technique (Static, Dynamic) Condition (Varicose Vein, Lymphedema, Leg Ulcer) Distribution (E-commerce, Hospital) - Global Forecast to 2030 |
||||||
カスタマイズ可能
|
圧迫療法の市場規模、シェア、予測、動向分析:製品別(包帯、ストッキング、テープ、ポンプ)手技別(静的、動的)状態別(下肢静脈瘤、リンパ浮腫、下腿潰瘍)流通別(eコマース、病院) - 2030年までの世界予測 |
出版日: 2024年08月01日
発行: Meticulous Research
ページ情報: 英文 270 Pages
納期: 5~7営業日
|
圧迫療法市場は、2024年から2030年までのCAGRが3.8%で、2030年には58億8,000万米ドルに達すると予測されます。
広範な1次調査と2次調査を実施し、圧迫療法市場のシナリオを詳細に分析しました。当レポートでは、業界の主要な促進要因、阻害要因、課題、機会を分析しています。圧迫療法市場の成長は、主に高齢者人口の増加、慢性疾患の有病率の増加、スポーツ外傷・事故の増加、整形外科手術の増加によってもたらされます。さらに、下肢静脈瘤や深部静脈血栓症(DVT)の症例が増加していること、予防措置として圧迫療法製品が徐々に受け入れられていること、圧迫療法の最小限の副作用と幅広い特典がこの市場の成長をさらに後押ししています。
さらに新興国は、この市場で活動する企業に大きな成長機会を提供すると期待されています。しかし、代替技術の採用や圧迫療法に対する不十分な償還構造が、市場成長に影響を与える主な課題となっています。
当レポートでは、4年間(2020-2024年)における製品ポートフォリオの提供、地域情勢、業界をリードする企業が採用した主な戦略的発展などの広範な評価に基づく競合情勢を提供しています。
(注:上位5社のSWOT分析を掲載)
Compression Therapy Market Size, Share, Forecast, & Trends Analysis by Product (Bandages, Stockings, Tapes, Pumps) Technique (Static, Dynamic) Condition (Varicose Vein, Lymphedema, Leg Ulcer) Distribution (E-commerce, Hospital)-Global Forecast to 2030
The compression therapy market is expected to reach $5.88 billion by 2030, at a CAGR of 3.8% from 2024 to 2030.
Following extensive secondary and primary research and in-depth analysis of the compression therapy market scenario. This report analyzes key industry drivers, restraints, challenges, and opportunities. The growth of the compression therapy market is primarily driven by the rising geriatric population, the increasing prevalence of chronic diseases, the growing number of sports injuries & accidents, and the growth in orthopedic procedures. In addition, the increasing cases of varicose veins and deep vein thrombosis (DVT), the gradual acceptance of compression therapy products as a preventive measure, and the minimal side effects and wide-ranging benefits of compression therapy further support the growth of this market.
Furthermore, emerging economies are expected to provide significant growth opportunities for the players operating in this market. However, the adoption of alternative technologies and an inadequate reimbursement structure for compression therapies are some of the major challenges impacting the market growth.
This report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2020-2024). The key players operating in the compression therapy market are 3M Company (U.S.), Essity Aktiebolag (publ) (Sweden), Bio Compression Systems, Inc. (U.S.), Arjo AB (Sweden), Convatec Inc. (U.S.), Cardinal Health, Inc. (U.S.), PAUL HARTMANN AG (Germany), Medline Industries, Inc. (U.S.), Julius Zorn, Inc. (U.S.), DJO, LLC (U.S.), Smith & Nephew plc (U.K.), medi GmbH & Co. KG (Germany), and SIGVARIS AG (Switzerland).
Based on product, the compression therapy market is segmented into bandages, garments, sequential/intermittent pneumatic compression pumps, and other pressure pumps. In 2024, the garments segment is expected to account for the largest share of 41% of the compression therapy market. The segment's large share is driven by the growing geriatric population with chronic diseases such as diabetes and varicose veins. According to data from the International Diabetes Federation (IDF) Diabetes Atlas, the prevalence of diabetes in individuals aged 20-79 years is expected to increase to 517 million in 2045 from 463 million in 2019. Additionally, the increased demand for compression therapy garments among healthcare professionals and the general population for long-term treatment options also contributes to the segment's large market share.
Based on technique, the compression therapy market is segmented into static and dynamic compression therapy. In 2024, the static compression therapy segment is expected to account for the larger share of the compression therapy market. The segment's large share is attributed to the widespread adoption of static compression therapy due to its benefits, including enhanced comfort during extended use, cost-effectiveness, user-friendly application, and the reliable delivery of consistent pressure.
Based on condition, the compression therapy market is segmented into varicose veins, deep vein thrombosis, lymphedema, and leg ulcers. In 2024, the varicose veins segment is expected to account for the largest share of the compression therapy market. The segment's large share is attributed to the rising geriatric population prone to vein-related disorders, the increase in secondary disorders associated with vein issues, and the rising prevalence of obese individuals who are at a higher risk of developing varicose veins.
Based on distribution channel, the compression therapy market is segmented into hospitals & clinics, pharmacies & retailers, e-commerce, and other distribution channels. In 2024, the pharmacies & retailers segment is expected to account for the largest share of the compression therapy market. The segment's large share is attributed to the growing demand for compression therapy products and their wide accessibility through pharmacies that operate around the clock.
Based on facility, the compression therapy market is segmented into healthcare settings and home-care settings. In 2024, the healthcare settings segment is expected to account for the larger share of the compression therapy market. This segment's large share is attributed to healthcare providers' recommendations to use compression therapy solutions for people at risk of deep vein thrombosis and obesity, and the use of compression solutions to manage chronic venous insufficiency.
An in-depth analysis of the geographical scenario of the compression therapy market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each area.
Based on geography, the compression therapy market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The Asia-Pacific market is slated to register the highest growth rate during the forecast period due to growing markets such as India (CAGR 5.9%) and China (CAGR 6.1%). The growth of this regional market is attributed to the extensive use of compression therapy among the region's elderly population, particularly those dealing with orthopedic issues, injuries, or secondary conditions such as obesity, hypertension, and post-diabetic blood problems.
Compression Therapy Market Assessment-by Product
Note: Other garments include inflatable devices, liners, bands, belts, braces, and tubes.
Compression Therapy Market Assessment-by Technique
Compression Therapy Market Assessment-by Condition
Note: Other Conditions include Orthostatic Hypotension, Postural Hypotension, Dysautonomia (POTS), Ehlers-Danlos Syndrome (EDS), May-Thurner Syndrome (MTS), and Post-thrombotic Syndrome (PTS).
Compression Therapy Market Assessment-by Distribution Channel
Note: Other distribution channels include nursing care centers and home care settings.
Compression Therapy Market Assessment-by Facility
Compression Therapy Market Assessment-by Geography
(Note: SWOT analyses of the top 5 companies will be provided.)